Abstract
In this Backstory, we narrate our journey in establishing a multidisciplinary team for sarcoma research and uncovering vulnerabilities in chondrosarcoma cells associated with their NAD+ dependencies for survival.1 Our findings hold promise for exploitation, yielding a synergistic cytotoxic effect when combined with systemic therapy.
Original language | English |
---|---|
Article number | 101385 |
Journal | Cell Reports Medicine |
Volume | 5 |
Issue number | 1 |
DOIs |
|
State | Published - 16 Jan 2024 |
Bibliographical note
Publisher Copyright:© 2023 The Author(s)